Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Advocacy Leadership Conference: Reflections from an Accidental Rheumatology Advocate

Samantha C. Shapiro, MD  |  May 19, 2022

I was never really interested in politics. While my college friends were raving about their poli sci classes, I buried my nose in biochemistry textbooks. I thought politics and medicine didn’t mix, and I preferred it that way.

Samantha C. Shapiro, MD

Dr. Shapiro

But then I became the first rheumatologist at a federally qualified health center. On my first day, the referral list to see me included 1,245 patients.1 Obtaining medications to care for these patients was a daily struggle, as were my complaints about our broken system.2

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

I watched as patients deteriorated before my eyes while waiting for biologics. And then one day, I got an email soliciting applications for positions on ACR committees. I saw this as a chance to take action. The potential professional benefit to me as an academic rheumatologist shooting for promotion also motivated me to apply. A few months later, I became the newest member of the Insurance Subcommittee (ISC) of the Committee on Rheumatologic Care. I didn’t know much about insurance. But I was willing to learn.

ACR Insurance Subcommittee

The ISC meets once a month to advocate for coverage and payment policies that benefit rheumatology patients and providers alike. ACR members may submit complaints about unfair insurance practices via the ACR website. Then, the ISC uses the power of the ACR to write letters to and schedule meetings with payers to effect change.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For example, the ISC learned that multiple payers are denying apremilast in combination with biologics for patients with psoriatic arthritis and residual skin lesions. As a team, we drafted a letter to the payer in question to advocate for a policy change. Note: An editable version of the letter will soon be available online to all ACR members should they encounter similar trouble in their practices.3

In many ways, ISC work can feel like a game of Whac-A-Mole—when we knock one nasty policy down, another springs up in its wake. But it sure feels good to do something more than just complain.

Advocacy Leadership Conference

Two women pose on a street wtih the US Capitol visible in the background.

At the Advocacy Leadership Conference, Dr. Shapiro met up with a former mentor, Rebecca Manno, MD, MHS (left).

In May 2022, my fellow ISC members and I, as well as members of several other ACR committees, were invited to meet in Washington, D.C., at the Advocacy Leadership Conference (ALC). ALC includes committee meetings, but these aren’t the main event. The real draw is advocacy training, followed by the opportunity to meet with one’s members of Congress on Capitol Hill.

Page: 1 2 3 | Single Page
Share: 

Filed under:InsuranceLegislation & AdvocacyProfessional Topics Tagged with:ACR Capitol Hill visitACR Insurance Subcommittee (ISC)Advocacy Leadership Conferencecopay accumulatorsdrug costsworkforce shortage

Related Articles
    felipe caparros / shutterstock.com

    Copay Accumulator Programs Can Derail Rheumatologic Treatment Plans

    February 13, 2020

    As the medications for rheumatology become more expensive, the need for patient financial assistance becomes paramount. Unfortunately, commercially insured patients are finding it difficult to afford the exorbitant copays required by their plans, and the latest strategy of pharmacy benefit managers (PBMs) threatens to derail rheumatologic treatment goals. High deductible plans combined with copay accumulator…

    New Wins, Ongoing Challenges for ACR Insurance Subcommittee

    July 3, 2019

    Corrections to reimbursement system errors with Aetna and a Medicare contractor demonstrate the latest wins for all providers by the ACR’s Insurance Subcommittee. But the committee remains hard at work advocating for rheumatologists on several fronts.

    What to Expect in Healthcare Policy from the 2023 State Legislative Sessions

    February 21, 2023

    With 2023 state legislative sessions underway, early prevailing themes may forecast areas where we will see gains this year. Key issues include utilization management, copay accumulator bans, white bagging and pharmacy benefit manager reform.

    ACR Leads Resolution to Address Copay Accumulator Policies at AMA House of Delegates Meeting

    November 6, 2020

    If passed, the ACR-authored resolution will direct the AMA to advocate for copay accumulator bans at state and federal levels. Several other specialties and state medical associations have joined the resolution as cosponsors.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences